Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-9 of  9 results for ""Bevacizumab""

Your Filters

Collection : Universite De Franche-Comte (Ufc)
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer

Subjects: Bevacizumab; Biomarker; Metastatic colorectal cancer

  • Source: ISSN: 1590-8658 ; Digestive and Liver Disease ; https://univ-tours.hal.science/hal-04888278 ; Digestive and Liver Disease, 2025, 57 (1), pp.141 - 148. ⟨10.1016/j.dld.2024.07.022⟩.

Record details

Read More Add to Saved list
×
Academic Journal

Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial

Subjects: [SDV]Life Sciences [q-bio]

  • Source: ISSN: 1740-5025.

Record details

Read More Add to Saved list
×
Academic Journal

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

Subjects: FOLFOX; XELOX; adjuvant

  • Source: ISSN: 0923-7534.

Record details

Read More Add to Saved list
×
Academic Journal

Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.

Subjects: Colorectal cancer; Bevacizumab; FOLFIRI3

  • Source: ISSN: 1471-2407.

Record details

Read More Add to Saved list
×
Academic Journal

Concurrent losses of skeletal muscle mass, adipose tissue and bone mineral density during bevacizumab / cytotoxic chemotherapy treatment for metastatic colorectal cancer

Subjects: Body composition; Bone mineral density; CT-Scan

  • Source: ISSN: 0261-5614.

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study

Subjects: [SDV]Life Sciences [q-bio]

  • Source: ISSN: 1533-0028 ; Clinical Colorectal Cancer ; https://hal.science/hal-03487688 ; Clinical Colorectal Cancer, 2019, 18, pp.200 - 208.e1. ⟨10.1016/j.clcc.2019.04.006⟩.

Record details

Read More Add to Saved list
×
Academic Journal

Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients

Subjects: [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology; [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

  • Source: ISSN: 0312-5963.

Record details

Read More Add to Saved list
×
Academic Journal

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer

Subjects: Colorectal cancer; Therapeutics; Strategy

  • Source: ISSN: 1471-2407.

Record details

Read More Add to Saved list
×
Academic Journal

Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.

Subjects: [SDV]Life Sciences [q-bio]; [SDV.CAN]Life Sciences [q-bio]/Cancer

  • Source: ISSN: 1055-9965.

Record details

Read More Add to Saved list
×
  • 1-9 of  9 results for ""Bevacizumab""